{
  "first_published_at": "2010-09-13", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON093853", 
  "title": "Inhaled and intranasal corticosteroids: risk of psychological and behavioural side effects", 
  "tags": "{\"parsed_therapeutic\": [\"ear-nose-throat\", \"respiratory-disease-allergy\"], \"Audience:\": [\"Primary care\", \"Secondary care\"], \"Therapeutic area:\": [\"Ear, nose and throat\", \"Respiratory disease and allergy\"]}", 
  "_document_number": 185, 
  "label": null, 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/adverse_icon.png", 
  "therapeutic_area": [
    "ear-nose-throat", 
    "respiratory-disease-allergy"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Inhaled and intranasal corticosteroids: risk of psychological and behavioural side effects</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: September 2010</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!---->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<div id=\"dsuSynopsis\" class=\"yellow\">\r\n\t\t\t\t\t\t\t\t\t<div class=\"dsuArticlePadding\">\r\n\t\t\t\t\t\t\t\t\t<span id=\"dsuSynopsisTitle\"><b>Summary</b></span>\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<br>Psychological and behavioural side effects may occur in association with use of inhaled and intranasal formulations of corticosteroids<br>\t\r\n\t\t\t\t\t\t\t\t\t</div>         \t\t\r\n\t\t\t\t\t\t\t\t\t<div id=\"dsuSynopsisCut\">\r\n\t\t\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>Inhaled corticosteroids are used for the prevention of asthma. Intranasal corticosteroids are used in the management of hayfever, allergy, and some nasal conditions.</p><p>We have previously reminded healthcare professionals that psychiatric side effects can occur with all systemic steroids (See <a href=\"ssLINK/CON079173\">Drug Safety Update September 2007</a>).</p><p>A review of data for inhaled and intranasal corticosteroids suggests that in addition to the known systemic effects of these medicines, a range of psychological or behavioural effects may also occur. These include psychomotor hyperactivity, sleep disorders, anxiety, depression, and aggression (particularly in children).</p><p>Affective disorders may be more frequently reported in patients with asthma or allergy than in patients without these conditions; however, treatment with inhaled and intranasal corticosteroids is also widespread in these patient groups, as is treatment with some substances known to be associated with behavioural and sleep disorders (such as &#946;-receptor agonists).</p><div class=\"dull_highlight\">\r\n\t\t\t<p><strong>Advice for healthcare professionals:</strong></p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li>All patients (or their carers) should be informed of the important benefits of steroid treatment, and should be advised of these safety issues</li>\r\n\t\t\t\t<li>All patients (or their carers) who receive steroids should receive a Patient Information Leaflet and be encouraged to read it</li>\r\n\t\t\t\t<li>Patients should keep using their steroid medication, but should seek medical advice in the event of worrying symptoms or illness while taking steroids</li>\r\n\t\t\t</ul></div><p>&nbsp;</p><p><em>Article citation: Drug Safety Update Sept 2010, vol 4 issue 2: A4.</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>Inhaled corticosteroids are used for the prevention of asthma. Intranasal corticosteroids are used in the management of hayfever, allergy, and some nasal conditions.</p><p>We have previously reminded healthcare professionals that psychiatric side effects can occur with all systemic steroids (See <a href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ssLINK/CON079173\">Drug Safety Update September 2007</a>).</p><p>A review of data for inhaled and intranasal corticosteroids suggests that in addition to the known systemic effects of these medicines, a range of psychological or behavioural effects may also occur. These include psychomotor hyperactivity, sleep disorders, anxiety, depression, and aggression (particularly in children).</p><p>Affective disorders may be more frequently reported in patients with asthma or allergy than in patients without these conditions; however, treatment with inhaled and intranasal corticosteroids is also widespread in these patient groups, as is treatment with some substances known to be associated with behavioural and sleep disorders (such as &#946;-receptor agonists).</p><div class=\"dull_highlight\">\r\n\t\t\t<p><strong>Advice for healthcare professionals:</strong></p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li>All patients (or their carers) should be informed of the important benefits of steroid treatment, and should be advised of these safety issues</li>\r\n\t\t\t\t<li>All patients (or their carers) who receive steroids should receive a Patient Information Leaflet and be encouraged to read it</li>\r\n\t\t\t\t<li>Patients should keep using their steroid medication, but should seek medical advice in the event of worrying symptoms or illness while taking steroids</li>\r\n\t\t\t</ul></div><p>&#160;</p><p><em>Article citation: Drug Safety Update Sept 2010, vol 4 issue 2: A4.</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2010-09-01", 
  "date_last_modified": "2011-01-14", 
  "_assets": [], 
  "_item_id": 185, 
  "summary": "Psychological and behavioural side effects may occur in association with use of inhaled and intranasal formulations of corticosteroids", 
  "body": "Article date: September 2010\n\nInhaled corticosteroids are used for the prevention of asthma. Intranasal corticosteroids are used in the management of hayfever, allergy, and some nasal conditions.\n\nWe have previously reminded healthcare professionals that psychiatric side effects can occur with all systemic steroids (See [Drug Safety Update September 2007](http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ssLINK/CON079173)).\n\nA review of data for inhaled and intranasal corticosteroids suggests that in addition to the known systemic effects of these medicines, a range of psychological or behavioural effects may also occur. These include psychomotor hyperactivity, sleep disorders, anxiety, depression, and aggression (particularly in children).\n\nAffective disorders may be more frequently reported in patients with asthma or allergy than in patients without these conditions; however, treatment with inhaled and intranasal corticosteroids is also widespread in these patient groups, as is treatment with some substances known to be associated with behavioural and sleep disorders (such as β-receptor agonists).\n\nAdvice for healthcare professionals:  \n  \n  * All patients (or their carers) should be informed of the important benefits of steroid treatment, and should be advised of these safety issues  \n  * All patients (or their carers) who receive steroids should receive a Patient Information Leaflet and be encouraged to read it  \n  * Patients should keep using their steroid medication, but should seek medical advice in the event of worrying symptoms or illness while taking steroids  \n  \n \n\nArticle citation: Drug Safety Update Sept 2010, vol 4 issue 2: A4.\n"
}